The nucleus paragigantocellularis and opioid withdrawal-like behavior

Journal of Biomedical Science

Volumn 7, Issue 3, 2000, Pages 270-276

  Rockhold, Robin W ^a   Liu, Niansen ^a   Coleman, Dominick ^a   Commiskey, Stephen ^a   Shook, Jonathan ^a   Ho, Ing K ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Butorphanol; Glutamate; Locus ceruleus; Microdialysis; Nucleus paragigantocellularis; Opioid antagonists; Opioid withdrawal like behavior

Indexed keywords

KYNURENIC ACID; OPIATE; OPIATE ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; ELECTROSTIMULATION; EVOKED RESPONSE; GIGANTOCELLULAR RETICULAR NUCLEUS; LOCUS CERULEUS; MICRODIALYSIS; NERVE EXCITABILITY; NONHUMAN; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT;

EID: 0034031059     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02255476     Document Type: Article

References (45)

1. Aghajanian GK, Kogan JH, Moghaddam B. Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: An in vivo microdialysis study. Brain Res 636:126-130; 1994.
2. Akaoka H, Aston-Jones G. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J Neurosci 11: 3830-3839;1991.
3. Alreja M, Aghajanian GK. Opiates suppress a resting sodium-dependent inward current in addition to activating an outward potassium current in locus coeruleus neurons. J Neurosci 13:3525-3532;1993.
4. Andrezik JA, Chan-Palay V, Palay SL. The nucleus paragigantocellularis lateralis in the rat: Conformation and cytology. Anat Embryol 161:355-371;1981.
5. Astier B, Kitahama K, Denoroy L, Berod A, Jouvet M, Renaud B. Biochemical evidence for an interaction between adrenaline and nor-adrenaline neurons in the rat brainstem. Brain Res 397:333-340;1986.
6. Aston-Jones G, Astier B, Ennis M. Inhibition of noradrenergic locus coerulcus neurons by C1 adrenergic cells in the rostral ventral medulla. Neuroscience 48:371-381;1992.
7. Aston-Jones G, Ennis M, Pieribone VA, Nickell WT, Shipley MT. The brain nucleus locus coeruleus: Restricted afferent control of a broad efferent network. Science 234:734-736; 1986.
8. Beaulieu J, Champagne D, Drolet G. Enkephalin innervation of the paraventricular nucleus of the hypothalamus: Distribution of fibers and origins of input. J Chem Neuroanat 10:79-92; 1996.
9. Bozarth MA. Physical dependence produced by central morphine infusions: An anatomical mapping study. Neurosci Biobehav Rev 18: 373-383;1994.
10. Calvino B, Lagowska J, Ben-Ari Y. Morphine withdrawal syndrome: Differential participation of structures located within the amygdaloid complex and striatum of the rat. Brain Res 177;19-34;1979.
11. Christie MJ, Williams JT, Osborne PB, Bell-chambers CE. Where is the locus in opioid withdrawal? Trends Pharmacol Sci 18:134-140;1997.
12. Ellison DW, Beal MF, Martin JB. Amino acid neurotransmitters in postmortem human brain analyzed by high performance liquid chromatography with electrochemical detection. J Neurosci Methods 19:305-315;1987.
13. Ennis M, Aston-Jones G. Activation of locus coeruleus from nucleus paragigantocellularis: A new excitatory amino acid pathway in brain. J Neurosci 8:3644-3657;1988.
14. Ennis M, Aston-Jones G, Shiekhattar R. Activation of locus coeruleus neurons by nucleus paragigantocellularis or noxious sensory stimulation is mediated by intracoerulear excitatory amino acid neurotransmission. Brain Res 598: 185-195;1992.
15. Feng YZ, Rockhold RW, Ho IK. Norbinaltor-phimine precipitates withdrawal and excitatory amino acid release in the locus coeruleus of butorphanol- but not morphine-dependent rats. J Pharmacol Exp Ther 283:932-938; 1997.
16. Feng YZ, Zhang T. Rockhold RW, Ho IK. Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat. Neurochem Res 20:675-681;1995.
17. Feng YZ, Zhang T, Tokuyama S, Zhu H, Rockhold RW, Ho IK. Mu and delta opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence. Neurochem Res 21:63-71;1996.
18. Fort P, Luppi PH, Sakai K, Salvert D, Jouvet M. Nuclei of origin of monoaminergic, peptidergic, and cholinergic afferents to the cat tri-geminal motor nucleus: A double-labeling study with cholera-toxin as a retrograde tracer. J Comp Neurol 301:262-275;1990.
19. Guyenet PG, Young BS. Projections of nucleus paragigantocellularis lateralis to locus coeruleus and other structures in rat. Brain Res 406: 171-184;1987.
20. Ho IK, Feng YZ, Tokuyama S, Hoshi K, Rockhold RW. Glutamate in opioid dependence. Jpn J Psychopharmacol 17:175-180;1997.
21. Hoshi K, Ma TG, Ho IK. Naloxone-precipitated κ-opioid receptor agonist withdrawal increases glutamate levels in rat locus coeruleus. Eur J Pharmacol 314:301-306;1996.
22. Hoshi K, Ma T, Oh S, Ho IK. Increased release of excitatory amino acids in rat locus coeruleus in κ-opioid agonist dependent rats precipitated by nor-binaltorphimine. Brain Res 753:63-68; 1997.
23. Koob GF, Bloom FF. Cellular and molecular mechanisms of drug dependence. Science 242: 715-723;1988.
24. Liu N, Rockhold RW, Ho IK. Electrical stimulation of nucleus paragigantocellularis induces opioid withdrawal-like behavior in the rat. Pharmacol Biochem Behav 62:263-271;1999.
25. Liu N, Ho IK, Rockhold RW. Contribution of glutamatergic systems in locus coeruleus to nucleus paragigantoccllularis stimulation-evoked behavior. Pharmacol Biochem Behav 63:555-567;1999.
26. Maldonado R. Participation of noradrenergic pathways in the expression of opiate withdrawal: Biochemical and pharmacological evidence. Neurosci Biobehav Rev 21:91-104;1997.
27. Maldonado R, Feger J, Fournie-Zaluski MC, Roques BP. Differences in physical dependence induced by selective mu or delta opioid agonists and by endogenous enkephalin protected by peptidase inhibitors. Brain Res 520: 247-254;1990.
28. Maldonado R, Stinus L, Gold LH, Koob GF. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261:669-677; 1992.
29. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE. The effects of morphine and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517-532;1976.
30. McFadzean I, Lacey MG, Hill RG, Henderson G. Kappa opioid receptor activation depresses excitatory synaptic input to rat locus cocruleus neurons in vitro. Neuroscience 20:231-239; 1987.
31. Oh KW, Makimura M, Jaw SP, Hoskins B, Ho IK. Effects of beta-funaltrexamine on butorphanol dependence. Pharmacol Biochem Behav 42:29-34;1992.
32. Olpe HR. Steinmann M, Brugger F, Pozza MF. Excitatory amino acid receptors in rat locus coeruleus. Naunyn-Schmidebergs Arch Pharmacol 339:312-314;1989.
33. Paxinos G, Watson C. The Rat Brain in Stereo-taxic Coordinates, ed 2. Sydney, Academic Press, 1986.
34. Rasmussen K, Aghajanian GK. Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: Attenuation by lesions of the nucleus paragigantocellularis. Brain Res 505:346-350;1989.
35. Rasmussen K. Afferent effects on locus coeruleus in opiate withdrawal. Prog Brain Res 88: 207-216;1991.
36. Redmond DE Jr. Huang YH, Snyder DR, Maas JW. Behavioral effects of stimulation of the locus coeruleus in the stump-tailed monkey (Macaco arctoides). Brain Res 116:502-510; 1976.
37. Rockhold RW, Liu N, Sinchaisuk S. Ho IK. Electrical stimulation of nucleus paragiganto-cellularis (PGi) and evocation of opioid withdrawal-like behavior. Naunyn Schmiedebergs Arch Pharmacol 358:R178;1998.
38. Semba J, Kilo S, Toru M. Characterization of extracellular amino acids in striatum of freely moving rats by in vivo microdialysis. J Neural Transm 100:39-52;1995.
39. Shiekhattar R, Aston-Jones G. NMDA-receptor mediated sensory responses of brain noradrenergic neurons are suppressed by extracellular magnesium. Synapse 10:103-109;1992.
40. 2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opiate dependent rats. Brain Res 772:310-313;1996.
41. Tokuyama S, Wakabayashi H, Ho IK. Direct evidence for a role of glutamate in the expression of opioid withdrawal syndrome. Eur J Pharmacol 295:123-129;1996.
42. Wei E, Loh H, Way EL. Quantitative aspects of precipitated abstinence in morphine-dependent rats. J Pharmacol Exp Ther 184:398-403; 1973.
43. Williams JT, Christie MJ, North RA, Roques BP. Potentiation of enkephalin action by peptidase inhibitors in rat locus coeruleus in vitro. J Pharmacol Exp Ther 243:397-401;1987.
44. Zhang T, Feng Y, Rockhold RW, Ho IK. Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat. Life Sci 55:PL25-31;1994.
45. Zhu H, Rockhold RW, Ho IK. The role of glutamate in physical dependence on opioids. Jpn J Pharmacol 76:1-14;1998.